The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
tert-butyl 4-((6-((4-(benzo[d]thiazol-5-yl)-5-fluoropyrimidin-2-yl)amino)pyridin-3-yl)methyl)piperazine-1-carboxylate ID: ALA5286388
Max Phase: Preclinical
Molecular Formula: C26H28FN7O2S
Molecular Weight: 521.62
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)(C)OC(=O)N1CCN(Cc2ccc(Nc3ncc(F)c(-c4ccc5scnc5c4)n3)nc2)CC1
Standard InChI: InChI=1S/C26H28FN7O2S/c1-26(2,3)36-25(35)34-10-8-33(9-11-34)15-17-4-7-22(28-13-17)31-24-29-14-19(27)23(32-24)18-5-6-21-20(12-18)30-16-37-21/h4-7,12-14,16H,8-11,15H2,1-3H3,(H,28,29,31,32)
Standard InChI Key: JPOMSVWUCYBXCX-UHFFFAOYSA-N
Molfile:
RDKit 2D
37 41 0 0 0 0 0 0 0 0999 V2000
3.2138 2.2636 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.2138 1.4386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9275 1.0250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9275 0.2001 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2111 -0.2112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2111 -1.0362 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4946 -1.4453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4946 -2.2691 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7750 -2.6772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0636 -2.2618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3463 -2.6692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3654 -2.2521 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0851 -2.6595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7908 -2.2399 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7908 -1.4130 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.5009 -0.9930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5009 -0.1680 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.2089 0.2556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2089 1.0806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9275 -0.1495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9191 0.6752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2195 -1.3980 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.0711 -1.0056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3654 -1.4251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0636 -1.4381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7833 -1.0298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4986 0.2023 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4986 1.0273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7841 1.4398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7841 2.2648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0696 2.6772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3551 2.2648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4291 2.5197 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-0.9141 1.8523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4291 1.1847 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3551 1.4397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0696 1.0270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
18 20 1 0
18 21 1 0
16 22 2 0
15 23 1 0
23 24 1 0
24 12 1 0
10 25 1 0
25 26 2 0
26 7 1 0
5 27 1 0
27 28 2 0
28 2 1 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 33 1 0
33 34 1 0
34 35 2 0
35 36 1 0
36 32 1 0
36 37 2 0
37 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 521.62Molecular Weight (Monoisotopic): 521.2009AlogP: 5.08#Rotatable Bonds: 5Polar Surface Area: 96.37Molecular Species: NEUTRALHBA: 9HBD: 1#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: 10.28CX Basic pKa: 5.93CX LogP: 4.55CX LogD: 4.54Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.39Np Likeness Score: -1.73
References 1. Yuan K, Shen H, Zheng M, Xia F, Li Q, Chen W, Ji M, Yang H, Zhuang X, Cai Z, Min W, Wang X, Xiao Y, Yang P.. (2023) Discovery of Potent DYRK2 Inhibitors with High Selectivity, Great Solubility, and Excellent Safety Properties for the Treatment of Prostate Cancer., 66 (6): [PMID:36800260 ] [10.1021/acs.jmedchem.3c00106 ]